Summary & Overview
CPT 92523: Evaluation of Speech Sound Production and Language Comprehension
CPT code 92523 represents a comprehensive evaluation of speech sound production alongside language comprehension and expression, a critical service in the field of speech-language pathology. This code is widely recognized and utilized across the United States, supporting the assessment and diagnosis of communication disorders in outpatient therapy settings. The evaluation is essential for identifying speech and language difficulties, guiding treatment plans, and ensuring appropriate interventions for patients of all ages.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, provide coverage for services billed under CPT code 92523. The publication offers insights into payer coverage, clinical benchmarks, and relevant policy updates, equipping readers with a clear understanding of how this code is applied in practice. Additionally, the summary addresses associated therapy modifiers, relevant ICD-10 diagnoses, and related CPT codes, providing a comprehensive overview of billing and clinical requirements.
Readers will gain knowledge about the clinical context of CPT code 92523, its role in speech-language pathology, and the payer landscape for outpatient therapy services. The article also highlights important coding and documentation considerations, ensuring stakeholders are informed about current standards and practices.
CPT Code Overview
CPT code 92523 is used for the evaluation of speech sound production combined with the evaluation of language comprehension and expression. This service is typically performed by a speech-language pathologist in an outpatient therapy setting under a therapy plan of care. The procedure assesses both the ability to produce speech sounds and the understanding and use of language, providing a comprehensive evaluation for individuals with communication disorders.
Clinical & Coding Specifications
Clinical Context
A child presents to an outpatient speech-language pathology clinic with concerns regarding delayed speech and language development. The speech-language pathologist conducts a comprehensive evaluation using CPT code 92523, which includes assessment of the child's speech sound production as well as evaluation of their language comprehension and expression. The clinical workflow involves gathering a detailed history, performing standardized tests, observing the patient's communication abilities, and documenting findings to inform a therapy plan of care. This service is typically provided in an outpatient therapy setting under a therapy plan of care, and is performed by a speech-language pathologist.
Coding Specifications
-
Modifiers:
GP,GO, orGN: Therapy modifiers required for CPT code92523as it is defined as an “always therapy” service under Medicare. These modifiers indicate the type of therapy provided:GP: Services delivered under a physical therapy plan of careGO: Services delivered under an occupational therapy plan of careGN: Services delivered under a speech-language pathology plan of care
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
235Z00000X | Speech-Language Pathologist |
2355S0801X | Speech-Language Pathologist, Speech-Language Specialist |
2355S0800X | Speech-Language Pathologist, Speech-Language Pathologist |
These taxonomies represent providers who are qualified to perform speech-language pathology services, including specialists and general speech-language pathologists.
Related Diagnoses
-
R13.0,R13.10,R13.11,R13.12,R13.13,R13.14,R13.19- Dysphagia codes- These codes represent various types of swallowing disorders. They are clinically relevant to CPT code
92523as speech-language pathologists often evaluate both speech/language and swallowing functions, especially in patients with communication and swallowing difficulties.
- These codes represent various types of swallowing disorders. They are clinically relevant to CPT code
-
A69.0- Relapsing fever- May be relevant if the underlying condition affects speech or language function.
-
C09.0,C09.1,C09.8,C09.9,C10.0,C10.1,C10.2,C10.3,C10.4,C10.8,C10.9,C12,C13.0,C13.1, etc. - Malignant neoplasm codes- These codes represent various malignant neoplasms of the oral cavity, pharynx, and related structures. They are relevant to CPT code
92523as patients with these diagnoses may experience speech, language, or swallowing impairments requiring evaluation by a speech-language pathologist.
- These codes represent various malignant neoplasms of the oral cavity, pharynx, and related structures. They are relevant to CPT code
These diagnoses support medical necessity for the evaluation performed under CPT code 92523.
Related CPT Codes
-
92521- Evaluation of speech fluency- Used to assess the patient's ability to produce fluent speech, often in cases of stuttering or other fluency disorders. May be performed alongside
92523if both fluency and language are concerns.
- Used to assess the patient's ability to produce fluent speech, often in cases of stuttering or other fluency disorders. May be performed alongside
-
92522- Evaluation of speech sound production- Focuses solely on speech sound production without the language evaluation component.
92523includes this aspect but adds language comprehension and expression evaluation.
- Focuses solely on speech sound production without the language evaluation component.
-
92524- Behavioral and qualitative analysis of voice and resonance- Used to evaluate voice quality and resonance, which may be relevant if the patient has voice disorders. Can be performed in conjunction with
92523if voice issues are present.
- Used to evaluate voice quality and resonance, which may be relevant if the patient has voice disorders. Can be performed in conjunction with
These codes are commonly used together when a comprehensive speech and language assessment is needed, or as alternatives depending on the specific clinical presentation.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 92523 is $234.47 for Medicare, while the average commercial benchmark (BUCA) is higher at $275.15. Among individual commercial payers, Cigna and UnitedHealth Group have the highest mean rates at $349.14 and $329.66, respectively, with Aetna at the lower end among commercial payers at $227.32.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare shows the tightest range at $17.00, indicating relatively consistent reimbursement. In contrast, Cigna exhibits the widest spread at $194.00, followed by UnitedHealth Group at $187.50, reflecting greater variability in commercial rates. Blue Cross Blue Shield and BUCA also show substantial dispersion, while Aetna's range is moderate.
The table and chart below present a detailed breakdown of national mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.